
Foot Anatomy: A Guide to Tendons, Bones & How They Work Together
The Architecture of Every Step You Take Every time you stand, walk, run, or climb stairs, roughly 26 bones, 33 joints, and over 100
Medically Reviewed by
Dr. Paul Hanna, DO, RPVI
Board Certified Vascular Surgeon
Every week at South Florida Multispecialty Medical Group, patients come to us with the same fear written on their faces: “Doctor, I have a blockage, do I need open-heart surgery?” The honest answer? Sometimes yes. But often, the answer is no. And understanding the difference between angioplasty and bypass surgery is not just a clinical decision, it is one of the most important conversations we have with our patients before they leave our consultation room.
I’m Dr. Paul Hanna, a vascular surgeon at SFL Medical Group in Miami. In our hospital, we perform angiograms, angioplasties, stentings, and bypass surgeries regularly. Over the years of treating patients across South Florida, I have seen both procedures transform lives — and I have also seen what happens when the wrong one is chosen. This blog post exists so you walk away knowing exactly how we think through these decisions.
Before we talk procedures, we need to talk about the problem. Coronary artery disease (CAD) occurs when fatty plaque accumulates inside the walls of the coronary arteries, the vessels that deliver oxygen-rich blood to your heart muscle. Over time, this buildup narrows the arteries, restricts blood flow, and can cause symptoms like chest pain (angina), shortness of breath, and fatigue. At worst, a completely blocked artery triggers a heart attack.
The same disease process can affect peripheral arteries in the legs, arms, and other areas of the body, not just the heart. At our vascular surgery center in Miami, we see coronary artery disease, peripheral artery disease (PAD), and complex multi-vessel occlusions on a daily basis. The challenge isn’t always diagnosing the blockage. The challenge is deciding how aggressively to treat it — and with which tool.
Both angioplasty and bypass surgery are designed to restore adequate blood flow. But they accomplish that goal through very different means, carry different risk profiles, and suit different patient anatomies. That is why choosing between them is never arbitrary.

Angioplasty formally called percutaneous transluminal angioplasty (PTA) when used in peripheral vessels is a minimally invasive procedure. We insert a thin, flexible catheter through a small puncture, usually in the wrist or groin, and thread it through the arterial system to the site of the blockage. At SFL Medical Group, we begin with a diagnostic angiogram first: we inject contrast dye and use X-ray imaging to map exactly where the blockage is, how severe it is, and what the surrounding vessel anatomy looks like.
Once we identify a significant blockage, we advance a balloon-tipped catheter to the narrowed site. When inflated, the balloon compresses the plaque against the artery wall and widens the channel for blood flow. In the majority of cases, we then place a stent, a small mesh tube to hold the artery open. Most of the stents we use today are drug-eluting, meaning they release medication over time to prevent scar tissue from re-forming inside the vessel. This significantly reduces the risk of restenosis (the artery narrowing again).
What I tell patients before they go into the angioplasty suite is this: “You will likely feel nothing more than mild pressure. You will be awake. And most of the time, you will go home tomorrow morning.” That alone changes how people feel about the procedure.
Recovery is one of angioplasty’s greatest advantages. Most patients are discharged within 24 to 48 hours. They return to light activities within a few days and resume a near-normal routine within a week. Because there is no large incision, no general anesthesia for most cases, and no opening of the chest, the physical toll is significantly lower than open surgery.
After the procedure, we typically prescribe antiplatelet medications (to prevent clot formation around the stent), cholesterol-lowering drugs (to address the underlying plaque disease), and recommend supervised lifestyle changes. Follow-up visits include blood tests, EKGs, and in some cases stress tests to confirm the artery is staying open and the heart is responding well.

Coronary artery bypass grafting or CABG, pronounced “cabbage” is open-heart surgery. A cardiac surgeon harvests a healthy blood vessel, typically from the leg (the saphenous vein) or the chest wall (the internal mammary artery), and uses it to create a detour around the blocked portion of the coronary artery. Blood now flows through the graft, bypassing the blockage entirely and restoring circulation to the area of the heart that was starved of oxygen.
Bypass surgery requires general anesthesia, a sternotomy (opening the chest by splitting the breastbone), and in most traditional cases, a heart-lung bypass machine that takes over the function of the heart and lungs during the operation. It is a longer, more complex procedure and it demands a recovery process to match.
Patients undergoing bypass surgery typically spend five to seven days in the hospital, sometimes longer depending on how complex the case was or how the patient responds post-operatively. Full recovery takes six to twelve weeks. Physical activity is restricted for weeks. Cardiac rehabilitation, a supervised exercise and education program is strongly recommended and in many cases transforms long-term outcomes.
The upside? For the right patient, bypass surgery offers durable, long-term results that angioplasty cannot always match. Because the graft reroutes blood entirely around the problem, there is no risk of restenosis at that site. In many multi-vessel disease cases, bypass surgery reduces the need for repeat procedures over a five to ten-year period.
This is the part that matters most. In our hospital, the decision between angioplasty and bypass surgery is never made by a single number on a scan. We look at five key dimensions:

For patients with single-vessel or double-vessel disease meaning one or two arteries are blocked, angioplasty with stenting is usually our first recommendation. The procedure can address those blockages efficiently, with excellent short- and medium-term outcomes. Research confirms that angioplasty success rates in one or two-vessel disease are often comparable to CABG.
For patients with triple-vessel disease (all three major coronary arteries blocked), bypass surgery becomes the stronger option. It allows us to revascularize multiple territories of the heart in one operation, and long-term data consistently favors CABG in this population.
The left main coronary artery is the most critical vessel in the heart. It branches into two arteries that supply the majority of the left ventricle, the heart’s main pumping chamber. When this artery is significantly narrowed, we take that very seriously. Bypass surgery is typically the preferred treatment for left main disease because of the high-risk nature of any complication at that site. Angioplasty in the left main is possible in select patients but remains a nuanced, case-by-case decision.
Not all blockages are created equal. A short, straightforward narrowing in an accessible artery is an ideal candidate for angioplasty. Long-segment occlusions, heavily calcified plaques, or blockages located at arterial bifurcations (where arteries branch) are technically more challenging to treat with a balloon and stent and carry a higher risk of incomplete revascularization or restenosis. In those cases, we lean toward bypass.
Patients with diabetes represent a special group in vascular surgery. Diabetic arteries tend to develop more diffuse disease blockages spread out along long stretches of the vessel rather than concentrated in one spot. Studies, including landmark trials like FREEDOM and SYNTAX, have shown that diabetic patients with multi-vessel disease do significantly better with bypass surgery than with angioplasty over the long term. When I sit down with a diabetic patient who has three-vessel disease, my recommendation is almost always bypass, not because I am being aggressive, but because the data says their heart deserves the durability that surgery provides.
Bypass surgery is major surgery. Not every patient is fit enough to undergo general anesthesia and sternotomy. Elderly patients, those with severe lung disease, kidney failure, prior strokes, or other significant comorbidities may carry an unacceptably high surgical risk. In those cases, angioplasty even in scenarios where bypass would normally be preferred becomes the safer option. We have performed angioplasties on patients in their late seventies and early eighties who simply could not tolerate open-heart surgery, and we have gotten excellent results.
One scenario where the decision becomes almost automatic is an acute heart attack, a STEMI (ST-elevation myocardial infarction). When a coronary artery is completely blocked and a patient is in the middle of a heart attack, every minute that passes means more heart muscle dying. In that setting, emergency angioplasty (primary PCI) is the treatment of choice. We get the patient into the catheterization lab, open the artery with a balloon, place a stent, and restore blood flow, ideally within 90 minutes of hospital arrival.
After treating emergency cases like this at SFL Medical Group, the priority shifts to understanding the full picture: Are there other blockages? What is the patient’s overall coronary anatomy? Some of these patients may ultimately need bypass surgery in the weeks that follow, once they are stabilized and we have a complete map of their disease. But in the moment of crisis, angioplasty saves lives.
One thing patients often don’t realize is that angioplasty is not just a cardiac procedure. At our vascular surgery department in Miami, we perform peripheral angioplasty frequently for patients suffering from peripheral artery disease (PAD) blockages in the arteries of the legs, which cause leg pain, cramping, non-healing wounds, and in severe cases, limb-threatening ischemia.
For PAD, the same principles apply. Short-segment disease in accessible locations responds well to angioplasty with stenting. Long-segment occlusions or blockages in smaller, more distal vessels may require surgical bypass using a vein graft. For patients with diabetic foot disease or critical limb ischemia where tissue is dying and amputation is a real risk, we pursue revascularization aggressively, often combining angioplasty with wound care and other limb-salvage techniques to preserve the limb.
After treating patients facing potential amputation, restoring blood flow through targeted angioplasty or bypass has meant the difference between keeping their leg and losing it. That is not an abstraction, it is a reality we confront regularly in South Florida, where the prevalence of diabetes and vascular disease is significant.
If you have ever looked at your cardiac catheterization report and seen a number called the “SYNTAX score,” that is a quantitative measurement of how complex your coronary artery disease is. It factors in the number of blockages, their severity, their location, and several anatomical characteristics. A low SYNTAX score generally favors angioplasty. A high SYNTAX score generally favors bypass surgery. An intermediate score is where the conversation gets nuanced and where multidisciplinary heart team discussions become essential.
In our hospital, when a case falls into that intermediate zone, we convene a heart team: vascular surgeons, interventional cardiologists, and sometimes cardiac surgeons. We review the imaging together, consider the patient’s full clinical picture, and make a unified recommendation. That collaborative approach is what separates a good hospital from a great one. According to the National Heart, Lung, and Blood Institute, multidisciplinary evaluation is a cornerstone of best-practice coronary artery disease management.
| Feature | Angioplasty + Stenting | Bypass Surgery (CABG) |
|---|---|---|
| Procedure Type | Minimally invasive, catheter-based | Open-heart surgery with graft placement |
| Anesthesia | Local or light sedation | General anesthesia |
| Hospital Stay | 1-2 days | 5-7 days |
| Recovery Time | ~1 week | 6-12 weeks |
| Best For | 1-2 vessel disease, emergencies | Multi-vessel or left main disease |
| Diabetes Patients | Adequate for mild cases | Preferred for multi-vessel disease |
| Repeat Procedure Risk | Higher (restenosis possible) | Lower long-term repeat rate |
| Complication Risk | Lower | Higher due to open surgery |
| Long-Term Durability | Good for suitable candidates | Excellent for complex disease |

Before any patient at SFL Medical Group leaves our consultation, we make sure they understand three things: what their anatomy actually looks like, what each option truly offers, and what recovery will demand from them and their family. We do not rush this conversation.
Patients sometimes come in already decided. “I heard bypass surgery lasts longer, I want that.” Or: “I can’t afford to be off work for three months, give me the stent.” Both of those statements deserve a response, not a rubber stamp. Our job as vascular surgeons is not to validate a preference, it is to align the right intervention with the right anatomy and the right person.
We also discuss long-term management honestly. Both procedures require lifelong commitment to medications, dietary changes, exercise, and follow-up imaging. Neither angioplasty nor bypass surgery is a cure for arterial disease. They are powerful tools that buy time and restore quality of life but only if combined with the behavioral and pharmacological changes that address the root causes. Our guide on arterial disease vs venous disease explains more about how these underlying conditions develop over time.
If you are experiencing chest pain, shortness of breath with exertion, leg pain while walking, or non-healing wounds on your feet or legs, do not wait. These symptoms can be early or late signs of arterial disease and the earlier we evaluate, the more options remain on the table. The CDC reports that coronary artery disease is the most common type of heart disease in the United States, affecting millions every year.
At South Florida Multispecialty Medical Group, our vascular surgery team in Miami offers comprehensive evaluation, diagnostic angiography, and the full spectrum of interventional and surgical treatments. We see patients from across Miami-Dade, Broward, and Palm Beach counties, and we treat every case with the individualized attention it deserves. Whether you ultimately need a stent, bypass surgery, or a combination of both, our team will walk you through every step of that process.
Your arteries do not need to be perfect, they just need to work. And that is exactly what we are here to help with.
Dr. Paul Hanna is a board-certified vascular surgeon with specialized fellowship training in complex vascular interventions and minimally invasive endovascular techniques. He serves as Director of Vascular Surgery and General Surgery at South Florida Multispecialty Medical Group, with over a decade of experience treating vascular conditions affecting the limbs, aorta, and peripheral arterial system.
Trust & Transparency: Editorial Policy | Contact Us
More To Explore

The Architecture of Every Step You Take Every time you stand, walk, run, or climb stairs, roughly 26 bones, 33 joints, and over 100

Nearly 20 percent of U.S. adults report cracked skin on their feet, and in humid South Florida we see it surge every season once
©2026 South Florida Multispecialty Medical Group. All Rights Reserved.